Director of Technology at Evolve Biologics
Trevor Seelert is the Director of Technology at Evolve Biologics®. Evolve Biologics® is a dynamic clinical-stage biopharmaceutical company committed to developing treatments for patients with rare diseases. Our ground-breaking technology (PlasmaCap EBA®) has the potential to become the first major advancement in plasma protein extraction in over 75 years: improving the quality, purity, and consistency of plasma-derived therapies, and increasing the value of each liter of donor plasma relative to the existing ‘legacy’ technology. Trevor has over 10 years of bioprocess engineering experience focussing on plasma proteins, vaccine and mammalian cell culture downstream design. He is also an ASME BPE member, sitting on the polymeric and other non-metallic materials subcommittee.